Abstract
The azelastine/fluticasone intranasal spray is a new option for treating allergic rhinoconjunctivitis. With clinical efficacy and prompt onset of action, it may be associated with increased patient satisfaction and improved medication compliance in the initial treatment period.
| Original language | English |
|---|---|
| Pages (from-to) | 54-55 |
| Number of pages | 2 |
| Journal | Medicine Today |
| Volume | 16 |
| Issue number | 8 |
| Publication status | Published - 2015 |
Keywords
- allergic rhinoconjunctivitis
- azelastine
- fluticasone propionate
- nasal sprays
- treatment